Cortical Neurons in Dementia with Lewy Bodies

Migration, Crosslink

📖

Cortical Neurons in Dementia with Lewy Bodies

active

wiki page Created: 2026-04-02T07:19:37 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-cell-types-neurons-fkeletal-ldlb

📖 Wiki Page

cell782 wordssynced 2026-04-02

Cortical Neurons in Dementia with Lewy Bodies

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Cortical Neurons in Dementia with Lewy Bodies</th>
</tr>
<tr>
<td class="label">Feature</td>
<td>DLB</td>
</tr>
<tr>
<td class="label">Primary protein</td>
<td>α-Syn</td>
</tr>
<tr>
<td class="label">Hippocampus</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Cortical neurons</td>
<td>Diffuse loss</td>
</tr>
<tr>
<td class="label">Pathology type</td>
<td>Lewy bodies</td>
</tr>
</table>

Introduction

Cortical Neurons In Dementia With Lewy Bodies is a cell type relevant to neurodegenerative disease research. This page covers its role in brain function, involvement in disease processes, and significance for therapeutic strategies.

Overview

Dementia with Lewy bodies (DLB) is characterized by widespread cortical involvement with Lewy body pathology affecting multiple brain regions. Cortical neurons, particularly pyramidal cells and interneurons, demonstrate significant degeneration that underlies the cognitive, psychiatric, and motor features of the disease. [@outeiro2023]

Neuroanatomy

Cortical Structure

Layer Organization

Layer I: Molecular layer (sparse neurons)
Layer II: External granular (small pyramids)
Layer III: External pyramidal (pyramidal neurons)
Layer IV: Internal granular (stellate cells)
Layer V: Internal pyramidal (large pyramids)
Layer VI: Multiform layer (polymorphic)

Neuron Types

...

Cortical Neurons in Dementia with Lewy Bodies

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Cortical Neurons in Dementia with Lewy Bodies</th>
</tr>
<tr>
<td class="label">Feature</td>
<td>DLB</td>
</tr>
<tr>
<td class="label">Primary protein</td>
<td>α-Syn</td>
</tr>
<tr>
<td class="label">Hippocampus</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Cortical neurons</td>
<td>Diffuse loss</td>
</tr>
<tr>
<td class="label">Pathology type</td>
<td>Lewy bodies</td>
</tr>
</table>

Introduction

Cortical Neurons In Dementia With Lewy Bodies is a cell type relevant to neurodegenerative disease research. This page covers its role in brain function, involvement in disease processes, and significance for therapeutic strategies.

Overview

Dementia with Lewy bodies (DLB) is characterized by widespread cortical involvement with Lewy body pathology affecting multiple brain regions. Cortical neurons, particularly pyramidal cells and interneurons, demonstrate significant degeneration that underlies the cognitive, psychiatric, and motor features of the disease. [@outeiro2023]

Neuroanatomy

Cortical Structure

Layer Organization

Layer I: Molecular layer (sparse neurons)
Layer II: External granular (small pyramids)
Layer III: External pyramidal (pyramidal neurons)
Layer IV: Internal granular (stellate cells)
Layer V: Internal pyramidal (large pyramids)
Layer VI: Multiform layer (polymorphic)

Neuron Types

Pyramidal Neurons

Excitatory: Glutamatergic
Apical dendrites: Extend to layer I
Basal dendrites: Local connections
Markers: Tuj1, Cux1, Satb2

GABAergic Interneurons

Parvalbumin (PV): Fast-spiking
Somatostatin (SST): Dendrite-targeting
VIP: Interneuron-specific
Reelin: Cajal-Retzius

Affected Cortical Regions

Primary Regions

Frontal cortex: Executive dysfunction
Temporal cortex: Memory, language
Parietal cortex: Visuospatial
Occipital cortex: Visual hallucinations

Connectivity

Subcortical inputs: Thalamus, basal ganglia
Cortical connections: Association fibers
Neuromodulatory: Acetylcholine, 5-HT, NE

Pathophysiology in DLB

Lewy Body Pathology

α-Synuclein Accumulation

Lewy bodies: Intraneuronal inclusions
Lewy neurites: Axonal pathology
Brainstem type: Early
Cortical type: Diffuse

Distribution Pattern

Temporal lobe: Early involvement
Frontal cortex: Executive deficits
Anterior cingulate: Psychiatric symptoms
Primary sensory: Late

Mechanisms

α-Synuclein Toxicity

Aggregation: Fibril formation
Membrane binding: Membrane permeability
Organelle dysfunction: Mitochondria, ER
Synaptic dysfunction: Presynaptic terminals
Spread: Prion-like propagation

Neurotransmitter Deficits

Cholinergic

Severe loss: Up to 70% in cortex
Basal forebrain: NBM degeneration
Clinical correlation: Cognitive severity
Treatment target: AChE inhibitors

Dopaminergic

Substantia nigra: Moderate loss
Motor symptoms: Parkinsonism
Treatment implications: Levodopa

Serotonergic

Raphe nuclei: Variable involvement
Depression: Psychiatric features
Hallucinations: 5-HT2A changes

Neuroinflammation

Microglial activation: Chronic
Cytokine elevation: IL-1β, TNF-α
Astrocytic: Reactive changes
Peripheral immune: Blood-brain barrier

Comparison with Alzheimer's

Electrophysiology

Cortical Dysfunction

Network Oscillations

Alpha rhythm: Reduced power
Beta oscillations: Slowed
Gamma: Impaired coupling
Cortical slowing: EEG delta/theta

Neuronal Excitability

Pyramidal cells: Reduced firing
Inhibitory neurons: Disinhibition
Synaptic plasticity: LTPmechanisms/long-term-potentiation) impairment
Cortical hyperexcitability: Early

Therapeutic Implications

Pharmacological

Cognitive Symptoms

Cholinesterase inhibitors: Donepezil, rivastigmine
Memantine: NMDA antagonist
Limited efficacy: vs. AD

Psychiatric Symptoms

Antipsychotics: Avoid (severe sensitivity)
Pimavanserin: 5-HT2A inverse agonist
Antidepressants: SSRIs, SNRIs

Motor Symptoms

Levodopa: Modest benefit
Dopamine agonists: Limited
Parkinsonism: Variable response

Non-Pharmacological

Cognitive stimulation: Benefit
Physical exercise: Maintain function
Sleep hygiene: REM behavior disorder
Visual management: Reduce hallucinations

Disease-Modifying Approaches

α-Syn aggregation inhibitors: In trials
Immunotherapy: Active/passive
Neurotrophic: Support neurons
Anti-inflammatory: Modulation

Research Models

Animal Models

α-Syn transgenic: A53T, A30P
Viral vectors: AAV-α-syn
Transgenic: Thy1-α-syn
DLB models: Combined pathology

In Vitro Models

iPSC cortical neurons: Patient-derived
Neuronal cultures: α-Syn aggregation
Organoids: Cortical circuits
Co-cultures: Glia-neuron

Clinical Significance

Diagnostic Criteria

Core Features

Fluctuating cognition: Variability
Visual hallucinations: Detailed, formed
Parkinsonism: Bradykinesia, rigidity
REM sleep behavior disorder: Loss of atonia

Supportive Features

Low uptake: DaTscan
Prominent depression
Delusions
Sensitivity to antipsychotics

Biomarkers

CSF: α-Synuclein (decreased)
Imaging: MRI, PET
Sleep: Polysomnography
Genetics: GBA, SNCA

External Links

[PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
[Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
[Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data

📖 View canonical wiki page →

Related Entities

cell-types-neurons-fkeletal-ldlb

▸Metadataorigin_type: v1_polymorphic_backfill

slug	cell-types-neurons-fkeletal-ldlb
kg_node_id	None
entity_type	cell
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-c12fecca4d4e
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'cell-types-neurons-fkeletal-ldlb'}
_schema_version	1

📊 Evidence Profile Foundational

Evidence Balance

+0%

Certainty

95%

Debates

0

Incoming

19

Outgoing

22

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

Cortical Neurons in Dementia with Lewy Bodies

Cortical Neurons in Dementia with Lewy Bodies

Introduction

Overview

Neuroanatomy

Cortical Structure

Layer Organization

Neuron Types

Cortical Neurons in Dementia with Lewy Bodies

Introduction

Overview

Neuroanatomy

Cortical Structure

Layer Organization

Neuron Types

Pyramidal Neurons

GABAergic Interneurons

Affected Cortical Regions

Primary Regions

Connectivity

Pathophysiology in DLB

Lewy Body Pathology

α-Synuclein Accumulation

Distribution Pattern

Mechanisms

α-Synuclein Toxicity

Neurotransmitter Deficits

Cholinergic

Dopaminergic

Serotonergic

Neuroinflammation

Comparison with Alzheimer's

Electrophysiology

Cortical Dysfunction

Network Oscillations

Neuronal Excitability

Therapeutic Implications

Pharmacological

Cognitive Symptoms

Psychiatric Symptoms

Motor Symptoms

Non-Pharmacological

Disease-Modifying Approaches

Research Models

Animal Models

In Vitro Models

Clinical Significance

Diagnostic Criteria

Core Features

Supportive Features

Biomarkers

See Also

External Links

💬 Discussion